14/1 2020 17:49 Cloverfield 4
80863 Jon Sigurdsson, President & CEO, comments: "The preliminary results for the
fourth quarter are disappointing while sales for the full year are strong with
growth of 16% in local currency and 5% organic growth. Despite the temporary
slowdown in prosthetics sales in the fourth quarter, we are confident that our
market position continues to be strong and we expect continued organic growth in
2020. Profitability for the full year was lower than we expected which can
largely be attributed to lower than expected sales in Q4 2019."
https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=917914&lang=en
fourth quarter are disappointing while sales for the full year are strong with
growth of 16% in local currency and 5% organic growth. Despite the temporary
slowdown in prosthetics sales in the fourth quarter, we are confident that our
market position continues to be strong and we expect continued organic growth in
2020. Profitability for the full year was lower than we expected which can
largely be attributed to lower than expected sales in Q4 2019."
https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=917914&lang=en
15/1 2020 13:50 Martin7100 280904 Har fulgt dem i længere tid .... faktisk flere år nu, men de kommer aldrig ud af deres dødvande og derfor bliver det ALDRIG en investering i mine øjne.
Jeg købte i dec.-17 lige under kurs 26, så jeg klager da ikke - dobbelt op på to år. Dødvande kan jeg da ikke få øje på.
